Human Presenilin-1 delivered by AAV9 rescues impaired γ-secretase activity, memory deficits, and neurodegeneration in Psen mutant mice
Open Access
- 10 October 2023
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 120 (42)
Abstract
Mutations in the Presenilin ( PSEN1 and PSEN2 ) genes are the major cause of early-onset familial Alzheimer’s disease (FAD). Presenilin (PS) is the catalytic subunit of the γ-secretase complex, which cleaves type I transmembrane proteins, such as Notch and the amyloid precursor protein (APP), and plays an evolutionarily conserved role in the protection of neuronal survival during aging. FAD PSEN1 mutations exhibit impaired γ-secretase activity in cell culture, in vitro, and knockin (KI) mouse brains, and the L435F mutation is the most severe in reducing γ-secretase activity and is located closest to the active site of γ-secretase. Here, we report that introduction of the codon-optimized wild-type human PSEN1 cDNA by adeno-associated virus 9 (AAV9) results in broadly distributed, sustained, low to moderate levels of human PS1 (hPS1) expression and rescues impaired γ-secretase activity in the cerebral cortex of Psen mutant mice either lacking PS or expressing the Psen1 L435F KI allele, as evaluated by endogenous γ-secretase substrates of APP and recombinant γ-secretase products of Notch intracellular domain and Aβ peptides. Furthermore, introduction of hPS1 by AAV9 alleviates impairments of synaptic plasticity and learning and memory in Psen mutant mice. Importantly, AAV9 delivery of hPS1 ameliorates neurodegeneration in the cerebral cortex of aged Psen mutant mice, as shown by the reversal of age-dependent loss of cortical neurons and elevated microgliosis and astrogliosis. These results together show that moderate hPS1 expression by AAV9 is sufficient to rescue impaired γ-secretase activity, synaptic and memory deficits, and neurodegeneration caused by Psen mutations in mouse models.Keywords
Funding Information
- HHS | National Institutes of Health (R01NS041783)
- HHS | National Institutes of Health (RF1AG063520)
This publication has 41 references indexed in Scilit:
- The advent of AAV9 expands applications for brain and spinal cord gene deliveryExpert Opinion on Biological Therapy, 2012
- Familial Frontotemporal Dementia-AssociatedPresenilin-1 c.548G>TMutation Causes Decreased mRNA Expression and Reduced Presenilin Function in Knock-In MiceThe Journal of Neuroscience, 2012
- Inactivation of presenilins causes pre‐synaptic impairment prior to post‐synaptic dysfunctionJournal of Neurochemistry, 2010
- A Presenilin-1 Mutation Identified in Familial Alzheimer Disease with Cotton Wool Plaques Causes a Nearly Complete Loss of γ-Secretase ActivityJournal of Biological Chemistry, 2010
- Characterization of Age-Dependent and Progressive Cortical Neuronal Degeneration in Presenilin Conditional Mutant MicePLOS ONE, 2010
- Presenilins are essential for regulating neurotransmitter releaseNature, 2009
- Presenilins are required for maintenance of neural stem cells in the developing brainMolecular Neurodegeneration, 2008
- The presenilin hypothesis of Alzheimer's disease: Evidence for a loss-of-function pathogenic mechanismProceedings of the National Academy of Sciences, 2007
- APP Processing and Synaptic Plasticity in Presenilin-1 Conditional Knockout MiceNeuron, 2001
- Control of Memory Formation Through Regulated Expression of a CaMKII TransgeneScience, 1996